Gsg Advisors LLC Compugen LTD Transaction History
Gsg Advisors LLC
- $345 Billion
- Q2 2025
A detailed history of Gsg Advisors LLC transactions in Compugen LTD stock. As of the latest transaction made, Gsg Advisors LLC holds 10,245 shares of CGEN stock, worth $15,367. This represents 0.01% of its overall portfolio holdings.
Number of Shares
10,245
Previous 10,245
-0.0%
Holding current value
$15,367
Previous $13.1 Million
39.06%
% of portfolio
0.01%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding CGEN
# of Institutions
78Shares Held
16.2MCall Options Held
28.7KPut Options Held
48.3K-
Silverarc Capital Management, LLC2.9MShares$4.34 Million1.03% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny1.4MShares$2.09 Million0.0% of portfolio
-
Morgan Stanley New York, NY1.39MShares$2.08 Million0.0% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl1.07MShares$1.61 Million0.02% of portfolio
-
Macquarie Group LTD Australia, C31.02MShares$1.53 Million0.0% of portfolio
About COMPUGEN LTD
- Ticker CGEN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 86,624,600
- Market Cap $130M
- Description
- Compugen Ltd., a clinical-stage therapeutic discovery and development company, researches, develops, and commercializes therapeutic and product candidates in Israel, the United States, and Europe. The company's immuno-oncology pipeline consists of COM701, an anti-PVRIG antibody that is in Phase I clinical study used for the treatment of solid tu...